Primary Clinical Research

03/31/2026

COPD research is getting some love in the headlines — and we’re here for it.

We’re proud to be part of a study evaluating tozorakimab, an investigational option being explored for COPD.

Science + community = our favorite combo.

Friday's positive trial results for tozorakimab mark a significant inflexion point for AstraZeneca PLC (LSE:AZN, NASDAQ:AZN), arriving at a moment when the market had all but written off the drug's prospects and at a time when the pharmaceutical industry has been struggling to find treatments...

03/18/2026

🎉🎉🎉

03/17/2026

Luck was not on our side today… 🍀

But thankfully nobody was injured.

Shoutout to the amazing first responders who assisted! Thanks for your patience as we get appointments rescheduled. 🙏🏻

Unfortunately we will be closed the rest of today and tomorrow morning as a car accidentally drove into our building and repairs need to be made. Thank you for your understanding!

Edit: Praise Jesus not a single person was injured!!

01/19/2026

🕊️ Dr. Martin Luther King Jr. taught us that meaningful change happens when we serve others with purpose.

Our mission is rooted in that same belief — partnering with our community to advance health, expand access, and create opportunities for every patient to participate in research that shapes the future. ⚕️

Today, we honor his legacy by recommitting to that work. 🤍

01/04/2026

Join us in the pursuit to change patients’ lives. Each and every person in a clinical trial plays a powerful role.

12/24/2025

✨From our family to yours, we’re wrapping ourselves in holiday cheer (and a few ornaments 🎄) to wish you a season filled with warmth, laughter, and love. Merry Christmas and Happy Holidays! Thank you for being part of our journey… here’s to an amazing year ahead. ❤️

11/27/2025

📸 Teamwork makes the dream work! From all of us at Primary Clinical Research and McGill Family Practice, we’re grateful for each other… and for YOU. Wishing everyone a Happy Thanksgiving filled with joy, health, and togetherness! 🦃🍂

11/22/2025

Part 2 of healthcare workers doing non-clinical trauma care!! We have the best boss ever

11/21/2025

Say hello to our newest team members at Primary Clinical Research—Molly and Kennedy! 🚀 Their skills and energy are already inspiring us, and we can’t wait to see the impact they’ll make. We wrapped up the week with an unforgettable afternoon at iSmash.

Welcome to the team—you’re going to do incredible things here! 🙌

11/18/2025

Help us in wishing our AMAZING Principal Investigator, Dr. McGill, a very happy birthday!!!! 🎈

10/29/2025

Reach out for more details and to see if you or a loved one may qualify!
☎️ (402) 282-1502
📧 contact@pcresearch.health

📣MARITIME-CV is a Phase 3 study for people living with a cardiovascular condition and overweight or obesity. In this study, we are exploring if an investigational medicine (a monthly injection) is safe to use, and whether it can reduce the risk of cardiovascular events, such as heart attacks and stroke in people with cardiovascular conditions.

More details in the link below. ⬇️

The MARITIME-1 study examines obesity and other weight-related conditions such as hypertension or dyslipidemia, investigating a monthly injection

10/23/2025

📣 Join us this Friday at Werner Park for a FREE event!!! Hope to see you there! 🍭🎃👻